{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:42:34Z","timestamp":1768963354380,"version":"3.49.0"},"reference-count":33,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Eye Research"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1076\/ceyr.24.1.39.5427","type":"journal-article","created":{"date-parts":[[2003,2,13]],"date-time":"2003-02-13T09:01:13Z","timestamp":1045126873000},"page":"39-45","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats"],"prefix":"10.1080","volume":"24","author":[{"given":"Ana I.","family":"Vallelado","sequence":"first","affiliation":[{"name":"Instituto Universitario de Oftalmobiologia Aplicada (IOBA), University of Valladolid, Valladolid; Pharmaceutical Technology Department, University of Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Isabel","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Instituto Universitario de Oftalmobiologia Aplicada (IOBA), University of Valladolid, Valladolid; Pharmaceutical Technology Department, University of Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Calonge","sequence":"additional","affiliation":[{"name":"Instituto Universitario de Oftalmobiologia Aplicada (IOBA), University of Valladolid, Valladolid; Pharmaceutical Technology Department, University of Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Instituto Universitario de Oftalmobiologia Aplicada (IOBA), University of Valladolid, Valladolid; Pharmaceutical Technology Department, University of Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jos\u00e9","family":"Alonso","sequence":"additional","affiliation":[{"name":"Instituto Universitario de Oftalmobiologia Aplicada (IOBA), University of Valladolid, Valladolid; Pharmaceutical Technology Department, University of Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"329","volume":"98","author":"Hill JC","year":"1991","unstructured":"Hill JC, Maske R, Watson P. Corticosteroids in corneal graft rejection: Oral versus single pulse therapy. Ophthalmology. 1991;98:329\u2013333.","journal-title":"Watson P. Corticosteroids in corneal graft rejection: Oral versus single pulse therapy. Ophthalmology"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(13)31253-6"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1995.99"},{"key":"e_1_2_1_5_1","first-page":"212","article-title":"Penetrating keratoplasty in the rat: A model for the study of immunosuppressive treatment of graft rejection","volume":"33","author":"Herbort CP","year":"1989","unstructured":"Herbort CP, Matsubara M, Nishi M, Mochizuki M. Penetrating keratoplasty in the rat: A model for the study of immunosuppressive treatment of graft rejection. Jpn J Ophthalmol. 1989;33:212\u2013220.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_2_1_6_1","first-page":"184","article-title":"Phillips TM","volume":"9","author":"Belin MW","year":"1990","unstructured":"Belin MW, Bouchard CS, Phillips TM. Update on topical cyclosporin A. Cornea. 1990;9:184\u2013195.","journal-title":"Update on topical cyclosporin A. Cornea"},{"key":"e_1_2_1_7_1","first-page":"39","article-title":"G\u00e9mez S, Lopez MI, Calvo P, Herreras JM, Alonso MJ","volume":"17","author":"Juberias JR","year":"1998","unstructured":"Juberias JR, Calonge M, G\u00e9mez S, Lopez MI, Calvo P, Herreras JM, Alonso MJ. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat. Curr Eye Res. 1998;17:39\u201346.","journal-title":"Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat. Curr Eye Res"},{"key":"e_1_2_1_8_1","unstructured":"ARVO. The Association for Research in Vision and Oph-thalmology. Statement for the use of animals in ophthalmic and vision research. In: Handbook for the Use of Animals in Biomedical Research 2nd ed. Bethesda MD USA: Asso-ciation for Research in Vision and Ophthalmology 1993."},{"key":"e_1_2_1_9_1","first-page":"15","article-title":"Recommendations from the Declaration of Helsinki","author":"Declaration of Helsinki","year":"1996","unstructured":"Declaration of Helsinki. Recommendations from the Declaration of Helsinki. Curr Eye Res. 1996;15.","journal-title":"Curr Eye Res"},{"key":"e_1_2_1_10_1","first-page":"1063","article-title":"G\u00e9mez Amoza JL, Benoit JP","volume":"18","author":"Julienne MC","year":"1992","unstructured":"Julienne MC, Alonso MJ, G\u00e9mez Amoza JL, Benoit JP. Preparation on poly (DL-lactide\/glycolide) nanoparticules of controlled particle size distribution: Application of experimental designs. Drug Dev Ind Pharm. 1992;18: 1063\u20131077.","journal-title":"Preparation on poly (DL-lactide\/glycolide) nanoparticules of controlled particle size distribution: Application of experimental designs. Drug Dev Ind Pharm"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(93)90369-Q"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/27.8.1368"},{"key":"e_1_2_1_13_1","first-page":"23","article-title":"Penetrating corneal transplantation in the inbred rat: A new model","volume":"26","author":"Willians KA","year":"1985","unstructured":"Willians KA, Coster DJ. Penetrating corneal transplantation in the inbred rat: A new model. Invest Ophthalmol Vis Sci. 1985;26:23\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_14_1","first-page":"55","article-title":"Boeckx R","volume":"24","author":"Wang PP","year":"1991","unstructured":"Wang PP, Simpson E, Meucci V, Morrison M, Lunetta S, Zajac M, Boeckx R. Cyclosporine monitoring by fluores-cent polarization immunoassay. Clin Biochem. 1991;24: 55\u201358.","journal-title":"Cyclosporine monitoring by fluores-cent polarization immunoassay. Clin Biochem"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273949609069123"},{"key":"e_1_2_1_16_1","first-page":"148","article-title":"Chin-Fook T, Rice NSC, Jones BR","volume":"64","author":"Sheperd WFI","year":"1980","unstructured":"Sheperd WFI, Coster DJ, Chin-Fook T, Rice NSC, Jones BR. Effect of cyclosporine A on survival of corneal grafts in rabbits. Br J Ophthalmol. 1980;64:148\u2013153.","journal-title":"Effect of cyclosporine A on survival of corneal grafts in rabbits. Br J Ophthalmol"},{"key":"e_1_2_1_17_1","first-page":"208","article-title":"LOpez-Berenstein G, Yau JC","volume":"81","author":"Luke DR","year":"1992","unstructured":"Luke DR, Brunner LI, LOpez-Berenstein G, Yau JC. Phar-macokinetics of cyclosporin in bone marrow transplanta-tion: Longitudinal characterization of drug in lipoprotein fractions. J Pharm Sci. 1992;81:208\u2013211.","journal-title":"Phar-macokinetics of cyclosporin in bone marrow transplanta-tion: Longitudinal characterization of drug in lipoprotein fractions. J Pharm Sci"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/02652048909098016"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600790307"},{"key":"e_1_2_1_20_1","first-page":"31","article-title":"Poly (D,L-lactide-co-glycolide) micro and nanospheres as a way to prolong blood\/plasma levels of subcutaneously injected cyclosporin A","volume":"41","author":"Sanchez A","year":"1995","unstructured":"Sanchez A, Alonso MJ. Poly (D,L-lactide-co-glycolide) micro and nanospheres as a way to prolong blood\/plasma levels of subcutaneously injected cyclosporin A. Eur J Pharm Biopharm. 1995;41:31\u201337.","journal-title":"Eur J Pharm Biopharm"},{"key":"e_1_2_1_21_1","first-page":"656","article-title":"Alvarez H","volume":"2","author":"Tabbara KF","year":"1988","unstructured":"Tabbara KF, Gee SS, Alvarez H. Ocular bioavailability of cyclosporine after oral administration. Transplant Proc. 1988;2:656\u2013659.","journal-title":"Ocular bioavailability of cyclosporine after oral administration. Transplant Proc"},{"key":"e_1_2_1_22_1","first-page":"2477","article-title":"Effects of the immuno-suppressant FK506 on a penetrating keratoplasty rejection model in the rat","volume":"34","author":"Nishi M","year":"1995","unstructured":"Nishi M, Herbort CP, Matsubara M, MorishitaY, Nishimura M, Nieda M, Mori S, Mochizuki M. Effects of the immuno-suppressant FK506 on a penetrating keratoplasty rejection model in the rat. Invest Ophthalmol Vis Sci. 1995;34: 2477\u20132486.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_23_1","first-page":"489","volume":"40","author":"Wassef R","year":"1985","unstructured":"Wassef R, Cohen Z, Bernard L. Pharmacokinetic profiles of cyclosporine in rats: Influence of route of administration and dosage. Transplantation. 1985;40:489\u2013493.","journal-title":"Bernard L. Pharmacokinetic profiles of cyclosporine in rats: Influence of route of administration and dosage. Transplantation"},{"key":"e_1_2_1_24_1","first-page":"421","article-title":"Duffrier L","volume":"14","author":"Bouchard CS","year":"1995","unstructured":"Bouchard CS, Kappil JC, Duffrier L. The role of systemic cyclosporine dosing schedule on corneal allograft survival in the rat model. Curr Eye Res. 1995;14:421\u2013424.","journal-title":"The role of systemic cyclosporine dosing schedule on corneal allograft survival in the rat model. Curr Eye Res"},{"key":"e_1_2_1_25_1","first-page":"29","volume":"20","author":"Hess AD","year":"1988","unstructured":"Hess AD, Esa AH, Colombani PM. Mechanism of actin\u00b0 of cyclosporine: Effects of cells of the immune system and on subcellular events in T cell activation. Transplant Proc. 1988;20:29\u201340.","journal-title":"Colombani PM. Mechanism of actin\u00b0 of cyclosporine: Effects of cells of the immune system and on subcellular events in T cell activation. Transplant Proc"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.136.12.4348"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199407000-00006"},{"key":"e_1_2_1_28_1","first-page":"413","article-title":"Niederkorn JY","volume":"30","author":"Callanan DG","year":"1989","unstructured":"Callanan DG, Luckenbach MW, Fischer BJ, Peeler JS, Niederkorn JY. Histopathology of rejected orthotopic corneal grafts in the rat. Invest Opthalmol Vis Sci. 1989;30:413\u2013424.","journal-title":"Histopathology of rejected orthotopic corneal grafts in the rat. Invest Opthalmol Vis Sci"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90978-9"},{"key":"e_1_2_1_30_1","first-page":"1029","article-title":"Wallace AC","volume":"111","author":"Keown PA","year":"1987","unstructured":"Keown PA, Syiller CR, Wallace AC. Effect of cyclosporin on the kidney. J Pediat. 1987;111:1029\u20131033.","journal-title":"Effect of cyclosporin on the kidney. J Pediat"},{"key":"e_1_2_1_31_1","first-page":"759","article-title":"Ryffel B","volume":"3","author":"Mihatsch MJ","year":"1988","unstructured":"Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc. 1988;3 :759\u2013771.","journal-title":"Histopathology of cyclosporine nephrotoxicity. Transplant Proc"},{"key":"e_1_2_1_32_1","first-page":"1735","article-title":"Cyclosporine","volume":"321","author":"Kahan BD","year":"1989","unstructured":"Kahan BD. Cyclosporine. N Engl J Med. 1989;321:1735\u20131738.","journal-title":"N Engl J Med"},{"key":"e_1_2_1_33_1","first-page":"384","article-title":"Golden D, Van Buren CT","volume":"10","author":"Kahan BD","year":"1986","unstructured":"Kahan BD, Flechner SM, Lorber MI, Jensen C, Golden D, Van Buren CT. Complications of cyclosporin therapy. World J Surg. 1986;10:384\u2013390.","journal-title":"Complications of cyclosporin therapy. World J Surg"},{"key":"e_1_2_1_34_1","first-page":"546","article-title":"Cyclosporine A: Effectiveness and toxicity in a rat model","volume":"25","author":"Dieperine H","year":"1986","unstructured":"Dieperine H, Kemp E, Leyssac PP, Starklint H. Cyclosporine A: Effectiveness and toxicity in a rat model. Clin Nephrol. 1986;25:546\u2013550.","journal-title":"Clin Nephrol"}],"container-title":["Current Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1076\/ceyr.24.1.39.5427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:33:18Z","timestamp":1768919598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1076\/ceyr.24.1.39.5427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1076\/ceyr.24.1.39.5427"],"URL":"https:\/\/doi.org\/10.1076\/ceyr.24.1.39.5427","relation":{},"ISSN":["0271-3683","1460-2202"],"issn-type":[{"value":"0271-3683","type":"print"},{"value":"1460-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}